Work

Phase II study of lenalidomide (CC-5013) for patients with myelofibrosis

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.6510

Authors: S. Verstovsek, J. Cortes, D. Thomas, M. Beran, C. Koller, F. Giles, H. Kantarjian

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2246527915

Cites:

Cited by: 1

Related to: 10